Posts
July 23 2023
Tivic Health Systems, Inc. announced the closing of its Public Offering in the amount of $2,100,000. EG&S acted as counsel to the Placement Agent.
July 23 2023
PainReform Ltd. announced the closing of its Registered Direct offering in the amount of $1,500,000. EG&S acted as counsel to the Placement Agent.
July 22 2023
PainReform Ltd. announced the closing of its Registered Direct offering in the amount of $1,500,000. EG&S acted as counsel to the Placement Agent.
July 22 2023
First Wave BioPharma, Inc. announced the closing of its Public Offering in the amount of $2,100,000. EG&S acted as counsel to the Placement Agent.
July 21 2023
Asensus Surgical, Inc. announced the closing of its Registered Direct offering in the amount of $10,000,000. EG&S acted as counsel to the Placement Agent.
July 20 2023
PainReform Ltd. announced the closing of its Registered Direct offering in the amount of $2,700,000. EG&S acted as counsel to the Placement Agent.
July 20 2023
Tivic Health Systems, Inc. announced the closing of its Public Offering in the amount of $2,100,000. EG&S acted as counsel to the Placement Agent.
July 19 2023
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company for liver, metabolic and fibrotic diseases, announced the closing of its follow-on offering in the amount of $7,000,000. EGS acted as counsel to Maxim Group LLC, the sole placement agent in connection with the offering.